NASDAQ:CARA

Cara Therapeutics Short Interest Ratio and Short Volume

$28.51
+0.20 (+0.71 %)
(As of 04/16/2021 12:00 AM ET)
Add
Compare
Today's Range
$27.82
Now: $28.51
$28.73
50-Day Range
$18.08
MA: $21.32
$29.19
52-Week Range
$12.30
Now: $28.51
$29.65
Volume632,804 shs
Average Volume877,507 shs
Market Capitalization$1.42 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.7

Short Interest

Cara Therapeutics (NASDAQ:CARA) Short Interest Data

Current Short Volume2,740,000 shares
Previous Short Volume3,210,000 shares
Change Vs. Previous Month:-14.64%
Dollar Volume Sold Short$77.71 million
Short Interest Ratio / Days to Cover3.1
Last Record DateMarch, 31 2021
Outstanding Shares45,080,000 shares
Float Size38,700,000 shares
Short Percent of Float7.08%
Today's Trading Volume632,804 shares
Average Trading Volume877,507 shares
Today's Volume Vs. Average-27.89%

Short Interest Over Time


Cara Therapeutics (NASDAQ:CARA) Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
3/31/20212,740,000 shares $77.71 million -14.6%7.1%3.1 $28.36
3/15/20213,210,000 shares $64.62 million +4.6%8.3%6.3 $20.13
2/26/20213,070,000 shares $57.29 million +9.6%7.9%6.1 $18.66
2/12/20212,800,000 shares $51.38 million -4.4%7.2%5.8 $18.35
1/29/20212,930,000 shares $63.35 million -18.2%7.6%6.5 $21.62
1/15/20213,580,000 shares $66.16 million -6.8%9.2%8.2 $18.48
12/31/20203,960,000 shares $65.02 million +2.9%10.2%9.3 $16.42
12/15/20203,960,000 shares $59.99 million +2.9%10.2%9.3 $15.15
11/30/20203,850,000 shares $58.14 million +0.5%9.9%9.1 $15.10
11/15/20203,830,000 shares $56.19 million No Change10.1%9.3 $14.67
10/30/20203,830,000 shares $59.02 million -15.3%10.7%9.8 $15.41
10/15/20204,520,000 shares $62.24 million +2.5%12.6%11.6 $13.77
9/30/20204,410,000 shares $60.51 million +14.8%10.3%11.7 $13.72
9/15/20203,840,000 shares $49.69 million +2.4%9.0%10.3 $12.94
8/31/20203,750,000 shares $56.85 million +2.7%8.8%9.3 $15.16
8/14/20203,650,000 shares $55.04 million -1.1%8.5%8.5 $15.08
7/31/20203,690,000 shares $61.84 million -3.2%8.7%7.6 $16.76
7/15/20203,810,000 shares $62.64 million -5.0%9.0%7.4 $16.44
6/30/20204,010,000 shares $68.77 million +12.0%9.5%7.4 $17.15
6/15/20203,580,000 shares $63.76 million -2.2%8.5%6.6 $17.81
5/29/20203,660,000 shares $61.41 million -2.1%8.6%6.7 $16.78
5/15/20203,740,000 shares $59.35 million +14.0%8.8%6.6 $15.87
4/30/20203,280,000 shares $52.71 million -6.0%7.7%6.4 $16.07
4/15/20203,490,000 shares $55.07 million -5.4%8.2%6.8 $15.78
3/31/20203,690,000 shares $58.45 million -13.2%8.7%6.9 $15.84

Cara Therapeutics (NASDAQ:CARA) Short Interest FAQ

speech bubbles
speech bubbles











What is Cara Therapeutics' current short interest?

Short interest is the volume of Cara Therapeutics shares that have been sold short but have not yet been closed out or covered. As of March 31st, traders have sold 2,740,000 shares of CARA short. 7.08% of Cara Therapeutics' shares are currently sold short. View details.

What is a good short interest ratio for Cara Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. Cara Therapeutics currently has a short interest ratio of 3.0.

What is a good short interest percentage for Cara Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 7.08% of Cara Therapeutics' floating shares are currently sold short.

Is Cara Therapeutics' short interest increasing or decreasing?

Cara Therapeutics saw a drop in short interest in the month of March. As of March 31st, there was short interest totaling 2,740,000 shares, a drop of 14.6% from the previous total of 3,210,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Cara Therapeutics' float size?

Cara Therapeutics currently has issued a total of 49,877,000 shares. Some of Cara Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Cara Therapeutics currently has a public float of 38,700,000 shares.

How does Cara Therapeutics' short interest compare to its competitors?

7.08% of Cara Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to Cara Therapeutics: Perrigo Company plc (3.85%), Allakos Inc. (9.68%), Blueprint Medicines Co. (0.00%), Schrödinger, Inc. (8.07%), Galapagos NV (0.00%), Biohaven Pharmaceutical Holding Company Ltd. (0.00%), Sage Therapeutics, Inc. (0.00%), Hutchison China MediTech Limited (0.00%), Emergent BioSolutions Inc. (5.48%), and I-Mab (0.00%).

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Analog Devices, Inc. ($5.84 billion), Aon plc ($5.47 billion), Charter Communications, Inc. ($5.36 billion), ViacomCBS Inc. ($3.99 billion), Snap Inc. ($3.77 billion), Airbnb, Inc. ($2.90 billion), Peloton Interactive, Inc. ($2.43 billion), Discovery, Inc. ($2.38 billion), The Kroger Co. ($2.28 billion), and Expedia Group, Inc. ($2.18 billion). View all of the most shorted stocks.

What does it mean to sell short Cara Therapeutics stock?

Short selling CARA is an investing strategy that aims to generate trading profit from Cara Therapeutics as its price is falling. Cara Therapeutics' stock is trading up $0.20 today. To short Cara Therapeutics stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that Cara Therapeutics will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Cara Therapeutics?

A short squeeze for Cara Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CARA, which in turn drives the price of the stock up even further.

How often is Cara Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CARA, twice per month. The most recent reporting period available is March, 31 2021.



This page was last updated on 4/18/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.